Foghorn Therapeutics shares are trading higher after the company reported better-than-expected Q2 financial results.
Foghorn Therapeutics, Inc.
Foghorn Therapeutics, Inc. FHTX | 0.00 |
Foghorn Therapeutics shares are trading higher after the company reported better-than-expected Q2 financial results.
